Skip to NavigationSkip to content

News

Multiple drugmakers, including Pfizer, Sanofi and GlaxoSmithKline, plan to increase US list prices on more than 200 drugs in the United States.
The FDA’s Risk Evaluation and Mitigation Strategy (REMS), which began in 2012, failed to successfully police the companies creating opioids like...
The European Commission has approved Janssen’s nasal spray Spravato (esketamine), which is used to treat major depressive disorder (MDD) that has...
AstraZeneca has announced that budesonide-glycopyrroniunm-formoterol fumarate has been approved in China for the maintenance treatment of chronic...
The NHS has fast-tracked the drug Epidyolex, a cannabidiol (CBD), to be available for epilepsy treatment through the NHS in England starting on 6...
The FDA has approved the breast cancer drug Enhertu, developed by AstraZeneca and Daiichi Sankyo.
Galderma’s acne cream AKLIEF (trifarotene 50 mcg) has received approval by the European Union after reviewing its summary of product characteristics...
AstraZeneca has announced that it has agreed to sell the rights to Arimidex (anastrozole) and Casodex (bicalutamide) in Europe, as well as African...
The FDA has approved Merck & Co’s Ebola vaccine, Ervebo. This marks the first time they have approved a vaccine against the virus.
AbbVie have announced that the European Commission (EC) have granted marketing authorisation for RINVOQ (upadacitnib). It’s a daily selective...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches